CEO since 2020.
Born: 1976
Education and experience: Morten Henneveld has extensive international and medical device experience having worked as Director, Commercial Excellence for Coloplast during 2008-2012, including a period working in the USA, and then, based in Malmö, working as Managing Director, Sweden and Regional Vice President, Nordics for Biomet and subsequently Vice President, EMEA Spine for Zimmer Biomet from 2012-2016. Previously Morten was Senior Vice President, Business Transformation and Strategy for GN Group.
Other current roles: Board Member, SIME Diagnostics.
Holdings in OssDsign: 200 000 shares and 3 500 513 subscription options.
CFO since 2020.
Born: 1963
Education and experience: MBA, focused on Strategy/Finance from AGSM (Australian Graduate School of Management). Anders has many years of experience in senior positions that span over multiple industries which include production as well as service companies. Anders is an experienced Chief Financial Officer with a demonstrated history from a diverse range of industries such as digital sustainability, retail, lighting and electronics manufacturing, pharmaceuticals, banking, management consulting and software development in Sweden and internationally and has with good merits driven finance departments.
Other current roles: –
Holdings in OssDsign: 82 915 shares and 1 322 838 subscription options.
VP, Clinical and Medical Affairs since 2022
Born: 1979
Education and experience: Melanie has over 15 years of Clinical and Medical affairs experience in Medical Device Companies serving as the VP of Clinical Affairs at ApaTech Ltd, Director of Clinical Affairs at Baxter as well as holding roles within Boston Scientific, Medtronic and Dana Farber Cancer Institute. Melanie holds a Bachelor’s Degree in Biology and Psychology from Wheaton College in Norton, MA.
Other current roles: –
Holdings in OssDsign: 198 729 subscription options.
VP, US Sales since 2020.
Born: 1969
Education and experience: Bachelor of Arts in economics from Saint Olaf College (Minnesota, United States). Eric Patermobrings 25 years of sales and marketing experience in the neurosurgical and orthopedic segments. Most recently, Mr. Patermo served as Vice President of sales for Burst Biologics (Smart Surgical), a biopharmaceutical manufacturer focusing on technologies to promote bone healing. Prior to this he held various sales management and leadership roles in Spine and Orthobiologics companies, including as a primary member of the US commercial team for Apatech Ltd., a British company successfully sold to Baxter for around USD 330 million in March 2010.
Other current roles: –
Holdings in OssDsign: 398 880 subscription options.
CTO since 2024, previously VP, Strategy and Business Development since 2021
Born: 1972
Education and experience: Tom has over 20 years’ commercial and technical Board and Senior Management experience in Medical Device Companies as co-founder of ApaTech Ltd, R&D director with Baxter Inc, Managing Director of NuVasive (UK) Ltd and Chief Executive Officer of SIRAKOSS Ltd, amongst other advisory, consulting and executive roles. Tom holds a Masters’ degree in Mechanical Engineering and a PhD in Biomaterials from the University of London.
Other current roles: Entreprenuer-in-Residence, Department of Bioengineering, Imperial College of Science and Technology, London. Head of Commercial Strategy, Orthox Ltd, Oxford UK. Chairman, Additive Instruments Limited, London UK. Founder and Director of Perspective Device Consulting Ltd.
Holdings in OssDsign: 379 615 subscription options.
VP, Marketing since 2024.
Born: 1976
Education and experience: Steve has over 25 years of experience in marketing, sales, and engineering for medical device companies. His responsibilities have included Sr.VP Sales & Marketing Sharp Fluidics, VP Sales & Marketing NeoSurgical, Sr. Director Marketing Invuity, Global Director Marketing Zimmer Spine, and other advisory and management roles. Steve holds a Bachelor’s of Science in Mechanical Engineering from University of Massachusetts and a Master’s Science in Management Sciences from Northeastern University.
Other current roles: -
Holdings in OssDsign: 341 806 subscription options.
